Institutions / Sands Capital Alternatives, LLC
Sands Capital Alternatives, LLC
CIK 1846444 · Institution · as of Dec 31, 2025
Portfolio value
$518.47M
Positions
20
As of
Dec 31, 2025
Top holdings
Dec 31, 2025
| Company | Value | % of portfolio |
|---|---|---|
| Klaviyo, Inc. | $118.51M | 22.9% |
| Nu Hldgs Ltd | $114.86M | 22.2% |
| Beta Bionics, Inc. | $108.78M | 21.0% |
| Inhibikase Therapeutics, Inc. | $26.69M | 5.1% |
| DoorDash, Inc. | $21.66M | 4.2% |
| Coupang, Inc. | $20.53M | 4.0% |
| Samsara Inc. | $16.53M | 3.2% |
| Datadog, Inc. | $11.67M | 2.3% |
| Toast, Inc. | $10.71M | 2.1% |
| BioAge Labs, Inc.BIOA | $10.40M | 2.0% |
| Monday.Com Ltd | $10.01M | 1.9% |
| ServiceTitan, Inc. | $9.57M | 1.8% |
| 10x Genomics, Inc. | $7.86M | 1.5% |
| Acumen Pharmaceuticals, Inc. | $7.21M | 1.4% |
| Tarsus Pharmaceuticals, Inc. | $6.96M | 1.3% |
| Acrivon Therapeutics, Inc.ACRV | $5.12M | 1.0% |
| Snowflake Inc. | $4.44M | 0.9% |
| Taysha Gene Therapies, Inc.TSHA | $3.99M | 0.8% |
| Candel Therapeutics, Inc.CADL | $2.29M | 0.4% |
| Figma, Inc.FIG | $683.3K | 0.1% |
Activity
Dec 31, 2025
InsidersInstitutions
This fund's 13F position changes — what it's buying and selling.No quarter-over-quarter changes yet — position changes appear once we've ingested two consecutive 13F filings for this manager. We currently hold 1 quarter of holdings.